GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alkermes PLC (STU:8AK) » Definitions » Investments And Advances

Alkermes (STU:8AK) Investments And Advances : €58 Mil (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Alkermes Investments And Advances?

Alkermes's Investments And Advances for the quarter that ended in Mar. 2024 was €58 Mil.

Alkermes's quarterly Investments And Advances declined from Sep. 2023 (€100 Mil) to Dec. 2023 (€37 Mil) but then increased from Dec. 2023 (€37 Mil) to Mar. 2024 (€58 Mil).

Alkermes's annual Investments And Advances declined from Dec. 2021 (€203 Mil) to Dec. 2022 (€124 Mil) and declined from Dec. 2022 (€124 Mil) to Dec. 2023 (€37 Mil).


Alkermes Investments And Advances Historical Data

The historical data trend for Alkermes's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alkermes Investments And Advances Chart

Alkermes Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Investments And Advances
Get a 7-Day Free Trial Premium Member Only Premium Member Only 71.45 20.37 203.05 124.24 36.58

Alkermes Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 86.01 72.11 99.73 36.58 57.76

Alkermes Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


Alkermes (STU:8AK) Business Description

Traded in Other Exchanges
Address
1 Burlington Road, Connaught House, Dublin, IRL, D04 C5Y6
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several collaborative arrangements to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies.

Alkermes (STU:8AK) Headlines

No Headlines